 CAMBRIDGE, Mass., Feb. 12, 2021 GLOBE NEWSWIRE -- Vericel Corporation NASDAQ:VCEL, a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that its Board of Directors unanimously approved the termination of the Companys shareholder rights agreement, commonly referred to as a poison pill, which was originally scheduled to expire on August 15, 2021. The shareholder rights agreement was amended to accelerate the expiration date to February 11, 2021, effectively terminating the plan as of that date. 